Figure 6: Mechanism of Anti-EGFR resistance in head and neck cancer by activation of TLR4-MyD88 signaling. EGFR inhibition by cetuximab prevents Src activation, thus preventing MyD88 degradation, ...
Healthcare Asia Magazine on MSN
A*STAR disarms pathway protecting lung cancer cells
The discovery addresses resistance amongst patients after one to two years of treatment. Researchers at Agency for Science, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results